Table: SymBio Pharmaceuticals - 9-MTH group results

SymBio Pharmaceuticals

14/11/2023 07:15

Nov 14 (Reuters)- 
             SymBio Pharmaceuticals Limited 
             CONSOLIDATED FINANCIAL HIGHLIGHTS 
     (in billions of yen unless specified)                
                   9 months ended      9 months ended        Year to  
                  Sep 30, 2023        Sep 30, 2022      Dec 31, 2023  
                     LATEST             YEAR-AGO           LATEST     
                     RESULTS             RESULTS          FORECAST    
  Sales               4.42                7.36              5.60      
                   (-39.9 pct)                           (-44.0 pct)  
  Operating       loss 283 mln            1.59          loss 680 mln  
  Recurring       loss 156 mln            1.84          loss 549 mln  
  Net             loss 788 mln            1.56            loss 1.29   
  EPS            loss 19.89 yen         40.00 yen      loss 32.53 yen 
  EPS Diluted                           39.43 yen                     
  Ann Div                                  NIL               NIL      
  -Q2 div              NIL                 NIL                        
  -Q4 div                                  NIL               NIL      
  
  NOTE - SymBio Pharmaceuticals Limited. 
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4582.T